Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RHAG - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CEACAM3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
GRPR - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TRAF3IP3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IKZF2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SDK2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CEP57 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TNFRSF4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DEFB126 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MIR4640 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SETD1B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RUNDC3A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PIAS4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RUNX1T1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NAAA - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PLEKHO1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BCKDHB - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PRL - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ZNF443 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ZC3HAV1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on